(Reuters) – Mallinckrodt is seeking to postpone a $200 million opioid settlement payment, Bloomberg News reported on Thursday citing people with knowledge of the matter.
The drugmaker wants lenders to waive off provisions that would make Mallinckrodt a defaulter if it skipped the opioid payment due June 16, the report said.
Mallinckrodt did not immediately respond to a Reuters request for comment.
The company earlier this month said it was considering a second bankruptcy filing and other options after its lenders raised concerns over the $200 million payment.
Mallinckrodt emerged from bankruptcy last year after winning court approval for a reorganization plan that included a $1.7 billion settlement of the litigation.
(Reporting by Raghav Mahobe in Bengaluru; Editing by Krishna Chandra Eluri)
